Search research articles
Contact Us
Filters
Showing results (1-10 of 82) with videos related to
Page
of 9
Sort By:
Bulletin Du Cancer
|
September 6, 2013
[Evolving strategies over time for treatment of breast cancer]
Henri Roché
La Revue Du Praticien
|
July 28, 2004
[Medical treatments for breast cancer]
Henri Roché
Cancer Treatment Reviews
|
August 30, 2011
Docetaxel combined with targeted therapies in metastatic breast cancer
Javier Cortes, Henri Roché
Critical Reviews in Oncology/Hematology
|
December 31, 2002
Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer
Hans-Joachim Lück, Henri Roché
La Revue Du Praticien
|
December 6, 2018
Breast tumours
Florence Dalenc, Elvire Pons, Henri Roché
American Journal of Clinical Oncology
|
April 9, 2008
High-dose chemotherapy for patients with high-risk breast cancer: a clinical and economic assessment using a quality-adjusted survival analysis
Patricia Marino, Henri Roché, Jean-Paul Moatti, et al.
The Journal of Rheumatology
|
October 5, 2016
Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment
Michel Laroche, Marie Seniow, Henri Roché, et al.
International Journal of Technology Assessment in Health Care
|
August 23, 2005
Impact of uncertainty on cost-effectiveness analysis of medical strategies: the case of high-dose chemotherapy for breast cancer patients
Patricia Marino, Carole Siani, Henri Roché, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 1, 2014
An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers
Cécile Arellano, Ben Allal, Anwar Goubaa, et al.
Critical Reviews in Oncology/Hematology
|
July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?
Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Page
of 9
Search research articles
Search
Showing results (1-10 of 82) with videos related to
Sort By:
Page
of 9
Bulletin Du Cancer
|
September 6, 2013
[Evolving strategies over time for treatment of breast cancer]
Henri Roché
La Revue Du Praticien
|
July 28, 2004
[Medical treatments for breast cancer]
Henri Roché
Cancer Treatment Reviews
|
August 30, 2011
Docetaxel combined with targeted therapies in metastatic breast cancer
Javier Cortes, Henri Roché
Critical Reviews in Oncology/Hematology
|
December 31, 2002
Weekly paclitaxel: an effective and well-tolerated treatment in patients with advanced breast cancer
Hans-Joachim Lück, Henri Roché
La Revue Du Praticien
|
December 6, 2018
Breast tumours
Florence Dalenc, Elvire Pons, Henri Roché
American Journal of Clinical Oncology
|
April 9, 2008
High-dose chemotherapy for patients with high-risk breast cancer: a clinical and economic assessment using a quality-adjusted survival analysis
Patricia Marino, Henri Roché, Jean-Paul Moatti, et al.
The Journal of Rheumatology
|
October 5, 2016
Arthralgia Associated with Autoimmune Abnormalities under Aromatase Inhibitor Therapy: Outcome after Cessation of Treatment
Michel Laroche, Marie Seniow, Henri Roché, et al.
International Journal of Technology Assessment in Health Care
|
August 23, 2005
Impact of uncertainty on cost-effectiveness analysis of medical strategies: the case of high-dose chemotherapy for breast cancer patients
Patricia Marino, Carole Siani, Henri Roché, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
September 1, 2014
An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers
Cécile Arellano, Ben Allal, Anwar Goubaa, et al.
Critical Reviews in Oncology/Hematology
|
July 26, 2005
Taxanes in adjuvant breast cancer setting: which standard in Europe?
Mario Campone, Pierre Fumoleau, Emmanuelle Bourbouloux, et al.
Page
of 9